CanSino Biologics Inc.康希诺生物

Tianjin CanSino Biotechnology Inc. is an emerging biotechnology company founded in 2009, headquartered in China. The company is dedicated to vaccine research, development, and commercialization, with a focus on addressing pressing unmet medical needs by providing high-quality vaccines for China and other emerging markets at affordable prices. It has established bacterial and cell/viral culture pilot facilities in compliance with current GMP standards, and is capable of providing services to clients and partners for clinical trial material production within these facilities. The company operates within the Biotechnology and Health Care industries. Currently, there is no publicly available information on the company's last investment or investors.